A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome

NCT04900350 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: AK117
DRUG: Azacitidine

Sponsor

Akeso